Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Kidney Neoplasms × palbociclib × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 57 Sarcoma 6 Squamous Cell Carcinoma of Head and Neck 5 Ovarian Neoplasms 5 Neoplasms 5 Neoplasm Metastasis 5 Sarcoma, Ewing 4 Lymphoma, Non-Hodgkin 4 Rhabdomyosarcoma 3 Rhabdoid Tumor 3 Osteosarcoma 3 Neuroblastoma 3 Multiple Myeloma 3 Medulloblastoma 3 Glioma 3 Carcinoma, Non-Small-Cell Lung 3 Wilms Tumor 2 Prostatic Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Melanoma 2 Lymphoma 2 Liposarcoma 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Head and Neck Neoplasms 2 Estrogen Receptor-positive Breast Cancer 2 Ependymoma 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2

Interventions

aldesleukin 19 Sunitinib 18 Bevacizumab 14 Interferon-alpha 13 Gemcitabine 13 Cyclophosphamide 13 Interleukin-2 12 fludarabine phosphate 11 Everolimus 11 Peripheral Blood Stem Cell Transplantation 9 Sorafenib 8 Axitinib 8 Nivolumab 7 pembrolizumab 6 Ipilimumab 6 Filgrastim 6 Doxorubicin 6 sargramostim 5 Carboplatin 5 Capecitabine 5 cabozantinib 4 Thalidomide 4 Tacrolimus 4 Radiotherapy 4 Radiosurgery 4 Mycophenolic Acid 4 Magnetic Resonance Spectroscopy 4 Erlotinib Hydrochloride 4 Bortezomib 4 temsirolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07123090 2026-02-27

SPARCC

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡